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Alveolar type II (ATII) cells remain differentiated and express surfactant proteins when cultured at an air–
liquid (A/L) interface. When cultured under submerged conditions, ATII cells dedifferentiate and change
their gene expression proﬁle. We have previously shown that gene expression under submerged condi-
tions is regulated by hypoxia inducible factor (HIF) signaling due to focal hypoxia resulting from ATII cell
metabolism. Herein, we sought to further deﬁne gene expression changes in ATII cells cultured under
submerged conditions. We performed a genome wide microarray on RNA extracted from rat ATII cells
cultured under submerged conditions for 24–48 h after switching from an A/L interface. We found signif-
icant alterations in gene expression, including upregulation of the HIF target genes stanniocalcin-1
(STC1), tyrosine hydroxylase (Th), enolase (Eno) 2, and matrix metalloproteinase (MMP) 13, and we
veriﬁed upregulation of these genes by RT-PCR. Because STC1, a highly evolutionarily conserved glyco-
protein with anti-inﬂammatory, anti-apoptotic, anti-oxidant, and wound healing properties, is widely
expressed in the lung, we further explored the potential functions of STC1 in the alveolar epithelium.
We found that STC1 was induced by hypoxia and HIF in rat ATII cells, and this induction occurred rapidly
and reversibly. We also showed that recombinant human STC1 (rhSTC1) enhanced cell motility with
extended lamellipodia formation in alveolar epithelial cell (AEC) monolayers but did not inhibit the oxi-
dative damage induced by LPS. We also conﬁrmed that STC1 was upregulated by hypoxia and HIF in
human lung epithelial cells. In this study, we have found that several HIF target genes including STC1
are upregulated in AECs by a submerged condition, that STC1 is regulated by hypoxia and HIF, that this
regulation is rapidly and reversibly, and that STC1 enhances wound healing moderately in AEC monolay-
ers. However, STC1 did not inhibit oxidative damage in rat AECs stimulated by LPS in vitro. Therefore,
alterations in gene expression by ATII cells under submerged conditions including STC1 were largely
induced by hypoxia and HIF, which may be relevant to our understanding of the pathogenesis of various
lung diseases in which the alveolar epithelium is exposed to relative hypoxia.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The alveolar epithelium is composed of two main cell types,
alveolar type I (ATI) cells and alveolar type II (ATII) cells. ATI cells
are large squamous cells that cover over 95% of the alveolar surface
and are responsible for gas exchange. Cuboidal ATII cells make up
the remaining 5% of the alveolar surface. They secrete surfactant,
play an important role in ion transport, and contribute to theregulation of alveolar ﬂuid and epithelial repair after lung injury
[1]. It is well-established that ATII cells remain differentiated when
cultured in air–liquid (A/L) interface but transdifferentiate when
cultured under submerged conditions [2,3]. We have previously
shown that the downregulation of surfactant protein expression
under submerged conditions is induced by local hypoxia created
by ATII cell metabolism and mediated by hypoxia inducible factor
(HIF) [4]. Herein, we sought to further elucidate gene expression
changes in ATII cells cultured under submerged conditions, as
these gene expression changes might provide insight into the path-
ogenesis of diseases in which the alveolar epithelium is exposed to
hypoxia.
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corpuscles of Stannius, which are endocrine glands in the kidneys of
bony ﬁshes [5,6]. The mammalian STC1 is expressed in various
tissues including the heart, lung, liver, adrenal, kidney, prostate,
and ovary [7,8]. The STC1 gene is modulated in numerous develop-
mental, physiological and pathological processes, including cancer,
pregnancy, lactation, angiogenesis and organogenesis [9,10]. STC1
has been identiﬁed as one of the genes regulated by HIF-1 [11].
STC1 expression induces ischemia tolerance in mouse brains and
hearts, suggesting its possible role in cell survival under hypoxic
conditions [12,13]. STC1 also reduces the number of apoptotic lung
cancer epithelial cells following hypoxia [14], which suggests that
the induction of STC1 in a hypoxic microenvironment plays an
important role in tumor progression [9,11,15]. Additionally, new
functions of STC1 have recently been reported, including the regula-
tionof re-epithelialization inhumankeratinocytes [16], suppression
of inﬂammatory responses [17] and reduction of oxidative damage
and subsequent apoptosis [17–19]. However, there has been no
study of STC1 in alveolar epithelial cells (AECs). Because a gene array
in ATII cells cultured under submerged conditions revealed signiﬁ-
cant upregulation of STC1, we accessed the regulation and potential
anti-oxidant and wound healing functions of STC1.2. Materials and methods
2.1. Rat ATII cell isolation and culture
ATII cells were isolated from pathogen-free adult male
Sprague–Dawley rats, as previously described [4]. This research
was approved by the Institutional Animal Care and Use Committee
(IACUC) at National Jewish Health.2.2. Culture of rat ATII cells and Affymetrix microarray experiments
2.2.1. Switch experiment from an A/L interface to a submerged
condition
The rat ATII cells were cultured in DMEM containing 5% rat
serum (RS), glutamine, antibiotics, and 10 ng/ml keratinocyte
growth factor (KGF) for 6 days under A/L interface conditions. On
day 7, the A/L interface conditions were continued or switched to
submerged conditions for an additional 24–48 h. At 24 or 48 h,
total RNA was extracted and puriﬁed using an RNeasy kit (QIAGEN,
Valencia, CA). The samples were run on an Affymetrix Rat Gene 1.1
ST 24-sample Array (Affymetrix, Santa Clara, CA). Data from the
array were analyzed using Partek Genomics Suite (Partek, St. Louis,
MO) and Ingenuity Pathway Analysis (Ingenuity Systems). See the
Supplementary Materials for additional details.2.3. Switch experiment from a submerged condition to an A/L interface
condition
The rat ATII cells were cultured for 6 days under submerged
conditions. On day 7, the submerged conditions were continued
or switched to A/L interface conditions for an additional 24–48 h.2.4. Experiments with dimethyloxalyl glycine (DMOG)
The rat ATII cells were cultured with the HIF-a prolyl hydroxy-
lase inhibitor, DMOG (Cayman Chemical Company, Ann Arbor, MI),
to stabilize HIF. The cells were cultured with RS and KGF for 6 days
under either A/L interface, submerged, or A/L interface with 1 mM
DMOG conditions.2.5. HIF adenovirus
Rat ATII cells were transduced with Ad.mutHIF1a [20] or
Ad.GFP at a multiplicity of infection of 20 pfu/cell, as previously
described [21].
2.6. Wound closure assay in rat AEC monolayers with recombinant
human STC1 (rhSTC1)
Rat ATII cells were plated on collagen I (5 lg/cm2) (BD
Biosciences)-coated 24-well cell-culture plates in DMEM with
10% fetal bovine serum (FBS). On day 4, crisscross scratch wounds
were made with p10 pipette tips in the AEC monolayers and
wound closure was compared with or without rhSTC1 (BioVendor,
Brno, Czech Republic) at 24 h, as previously described [22].
2.7. Real time-PCR (RT-PCR)
The expression levels of genes were expressed as a ratio to the
expression of the constitutive probe cyclophilin B (CyB) (in house).
The speciﬁc primers and probes for tyrosine hydroxylase (Th),
STC1, enolase 2 (Eno2), matrix metalloproteinase 13 (MMP13),
glucose transporter 1 (Glut1) and uncoupling protein 2 (UCP2)
were purchased from Applied Biosystems (Foster City, CA).
2.8. Western blotting
Protein loading was normalized to b-actin. The primary
antibody was anti-STC1 antibody (R&D systems, Minneapolis, MN).
2.9. Immunoﬂuorescence-staining and measurement of lamellipodia
area
Rat AECs were ﬁxed at 1 h after wounding and stained with
phalloidin–tetramethylrhodamine B isothiocyanate (Sigma) and
DAPI (Vector Laboratories Inc., Burlingame, CA). The lamellipodia
areas were analyzed from the leading edge at the four corners of
crisscross wounds, as previously described [22].
2.10. 5-Bromo-2-deoxyuridine (BrdU) staining
The rat AECs were labeled with BrdU, and then BrdU incorpo-
rated into the cellular DNA was detected by immunostaining using
mouse monoclonal BrdU antibody (GE Healthcare Life Science,
Pittsburgh, PA) at 24 or 48 h after wounding. The labeling index
of at least 500 epithelial cells at the wound edge was determined
from three independent experiments.
2.11. Assessment of protein carbonyls in rat AECs stimulated by LPS
Rat ATII cells were plated on 12-well plates, on day 4 cells were
stimulated with 10 lg/ml LPS (Sigma) with and without 500 ng/ml
rhSTC1, and cell lysates were harvested at 24 h. Proteins from AEC
lysates was derivatised with dinitrophenyl (DNP)-hydrazone using
an OxyBlot Protein Oxidation Detection kit (Millipore, Billerica,
MA). See the Supplementary Materials for details.
2.12. Statistical analysis
All data are presented as means ± standard error of the mean
(SEM). One-way ANOVA was used to compare differences between
two or more groups. The post hoc Bonferroni/Dunn test was
used for multiple comparisons. Statistical signiﬁcance was set at
p < 0.05.
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3.1. STC1 and other HIF regulated genes are increased under
submerged condition or treatment with DMOG
To evaluate changes in gene expression due to submersion, we
conducted two switch experiments. After 6 days of culture under
the A/L interface conditions, switching to the submerged condition
for 24–48 h resulted in a dramatic up-regulation of many genes,
including the HIF-regulated genes Th, STC1, Eno2, and MMP13
(Table 1A and B). We conﬁrmed that these four genes were up-reg-
ulated at 6 days of culture under submerged conditions or A/L
interface conditions with DMOG in additional independent exper-
iments (Fig. 1A). Expression of Glut1, a well-known HIF-regulatory
gene, is shown as a positive control. We also observed that the pro-
tein level of STC1 was up-regulated at 6 days of culture under sub-
merged conditions or under A/L interface conditions with DMOG
(Fig. 1B). Transduction of rat ATII cells with an adenovirus express-
ing a mutant, constitutively active form of HIF1a also resulted in
an increase in STC1 mRNA (Fig. 1C).Table 1
The genes with the top 10 most highly increased or decreased expression levels under sub
after switching from culturing under A/L interface conditions. Bold genes are HIF target g
Gene symbol RefSeq p-Valu
(A)
Increased in submerged at 24 h
Fam70b NM_001106094 1.08E
Th NM_012740 3.88E
Dock6 NM_001108997 4.73E
Osap NM_001109556 7.10E
Stc1 NM_031123 9.23E
Tmem213 ENSRNOT00000018331 9.69E
Atp6v0a4 NM_001106591 3.46E
Car9 NM_001107956 3.40E
Hcrtr1 NM_013064 8.59E
Eno2 NM_139325 1.24E
Decreased in submerged at 24 h
Lgi3 NM_001107277 1.96E
Aqp5 NM_012779 0.0028
Angptl1 NM_001109383 1.27E
Retnla NM_053333 1.47E
Kcne2 NM_133603 6.57E
Akr1c14 NM_138547 4.54E
Slc43a3 NM_001107743 0.0002
Brms1l NM_001106731 7.21E
Accn2 NM_024154 0.0003
Akr1cl1 NM_001109900 0.0046
Gene symbol RefSeq p-Valu
(B)
Increased in submerged at 48 h
Fam70b NM_001106094 2.33E
Th NM_012740 1.06E
Osap NM_001109556 1.89E
Car9 NM_001107956 4.14E
Stc1 NM_031123 3.41E
Dock6 NM_001108997 2.93E
Fxyd4 NM_022388 2.60E
Ankrd34c NM_001106845 1.98E
Eno2 NM_139325 5.54E
Mmp13 NM_133530 2.54E
Decreased in submerged at 48 h
Retnla NM_053333 4.83E
Lgi3 NM_001107277 1.83E
Slc43a3 NM_001107743 4.28E
Aqp5 NM_012779 0.0005
Angptl1 NM_001109383 1.59E
Akr1c14 NM_138547 2.11E
Cyp2f4 NM_019303 0.0015
Brms1l NM_001106731 1.83E
Accn2 NM_024154 0.0001
Pde7b NM_080894 0.00453.2. The culture condition-associated changes in STC1 expression were
rapid and reversible
To evaluate whether the change in STC1 expression was revers-
ible, we performed two switch experiments. In the ﬁrst experiment,
after 6 days of culture under A/L interface, switching to the sub-
merged condition for an additional 24–48 h resulted in a dramatic
increase in STC1mRNA and protein levels (Fig. 2A and B). In the sec-
ond experiment, after 6 days of culture under the submerged con-
ditions, STC1 mRNA and protein levels were decreased by a
subsequent 24 h of culture under A/L interface conditions (Fig. 2C
and D). Hence, the effect of submersion was rapid and reversible.
3.3. STC1 enhances wound closure in the rat AEC monolayers
Acute respiratory distress syndrome (ARDS) results in the alve-
olar edema, where ATII cells are under focal alveolar hypoxia [23]
and the re-epithelialization of the alveolar epithelial initially occurs
by ATII cells [1,23]. STC1 is reported to regulate re-epithelialization
in human keratinocytes and human A549 lung cancer epithelialmerged conditions when compared to A/L interface conditions at 24 h (A) or 48 h (B)
enes. n = 3 independent experiments.
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Fig. 1. Submerged condition andHIF induce Th, STC1, Eno2 andMMP13 expression in rat ATII cells. (A) Rat ATII cells were cultured under either A/L interface, submerged, or A/L
interfacewith1 mMDMOGconditions for 6 days. ThemRNA levels of Th, STC1, Eno2,MMP13andGlut1weremeasuredbyRT-PCR. These levelswerenormalized toCyB.n = 3; (B)
the protein levels of STC1 in rat ATII cells cultured under either A/L interface, submerged, or A/L interfacewith 1 mMDMOGconditions for 6 daysweremeasured and normalized
to b-actin byWestern blotting. Upper: this blot is representative of one of three independent but reproducible experiments. Lower: relative intensity of STC1 byWestern blotting
analyzed by Image J software from three independent experiments (the intensity of STC1/b-actin of A/L condition on day 6 is designated as 1.00); (C) themRNA levels of STC1 in
rat ATII cells with HIF1a-overexpression by adenovirus were measured by RT-PCR. These levels were normalized to CyB. n = 4; values are means ± SEM; ⁄p < 0.05.
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epithelialization in primary rat AEC monolayers, wound closure
was compared with and without 500 ng/ml rhSTC1 at 24 h after
wounding. Wound closure was promoted by rhSTC1 (Fig. 3A), with
extended lamellipodia formation (Fig. 3B). However, rhSTC1 did not
stimulate cell proliferation at 24–48 h after wounding (Fig. 3C).
3.4. rhSTC1 does not protect rat AECs from LPS-induced oxidative
damage
A previous study reported that STC1 suppressed superoxide
generation and protein carbonyls with induction of uncoupling
protein 2 (UCP2) [17,19]. Therefore, we wondered whether STC1
would decrease oxidative damage with upregulation of UCP2 inrat AECs. To examine this issue, rat AEC monolayers were stimu-
lated by LPS with or without 500 ng/ml STC1 and the levels of oxi-
datively modiﬁed protein, carbonyl proteins, and the expression of
UCP2 were assessed. However, contrast to the effect of STC1 on
LPS-induced oxidative stress in macrophage or the murine lungs
where STC1 increases UCP2 and subsequent decreases oxidative
stress [17,19,25,26], in AECs STC1 does not reduce oxidative stress
and upregulate UCP2 levels (Fig. 3D and E).
3.5. STC1 is up-regulated in human lung epithelial cells
To determine whether STC1 would be up-regulated by hypoxia
and HIF in human lung epithelial cells, cells of the human bronchial
epithelial cell line 16HBE were exposed to a hypoxic condition (1%
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Fig. 2. The mRNA and protein levels of STC1 are changed rapidly due to culture conditions and the changes are reversible. (A,B) Rat ATII cells were cultured under either A/L
interface or submerged conditions for 24–48 h after culturing for 6 days under A/L interface conditions. The mRNA levels of STC1 were measured by RT-PCR. These levels were
normalized to CyB (A). The protein levels of STC1 were measured and normalized to b-actin by Western blotting (B). Upper: this blot is representative of one of three
independent but reproducible experiments. Lower: relative intensity of STC1 by Western blotting analyzed by Image J software from three independent experiments (the
intensity of STC1/b-actin of A/L condition on day 7 is designated as 1.00). (C,D) Rat ATII cells were cultured under either A/L interface or submerged conditions for 24–48 h
after 6 days under submerged conditions. The mRNA levels of STC1 (C) and the protein levels of STC1 (D) were measured. Upper: this blot is representative of one of three
independent but reproducible experiments. Lower: relative intensity of STC1 by Western blotting analyzed by Image J software from three independent experiments (the
intensity of STC1/b-actin of submerged condition on day 7 is designated as 1.00). Values are means ± SEM; ⁄p < 0.05.
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under A/L interface conditions with DMOG for 6 days. STC1 mRNA
levels were increased in both 16HBE cells exposed to hypoxia and
human ATII cells cultured in the A/L interface with DMOG (Supple-
mentary Fig. 1).4. Discussion
We demonstrated that STC1 was induced due to focal hypoxia,
the activation of HIF and under submerged conditions in rat AECs,
and that the expression of STC1 was changed rapidly and revers-
ibly by a change in culture conditions. We also found that wound
closure in the rat AEC monolayer was enhanced by rhSTC1 with
extended lamellipodia formation.
We previously reported that surfactant proteins were down-
regulated under submerged conditions, which was regulated by
oxygen tension through HIF signaling [4]. In a variety of clinical
settings, such as ARDS, pneumonia, pulmonary ﬁbrosis, or severe
small airway obstruction, there is focal alveolar hypoxia. Therefore,
to evaluate which genes were changed due to oxygen tension, we
conducted a genechip analysis using rat ATII cells from an experi-
ment employing a switch from A/L to submerged conditions. Wethen examined the 10 genes that showed the greatest increase or
decrease in expression under submerged conditions when com-
pared to A/L interface conditions at 24 or 48 h after switching from
A/L interface conditions. Among the top 10 genes showing higher
expression under submerged conditions, there were four known
HIF-regulated genes, Th, STC1, Eno2 and MMP13 [11,27–30]. The
present study is the ﬁrst to report that HIF and hypoxic conditions
regulated these genes in alveolar epithelial cells.
Wound healing is vital for the maintenance of alveolar integrity
after injury. ATII cells are thought to be the main progenitor cells
involved in restoring the alveolar epithelium after injury [1]. The
repair of epithelial monolayers following mechanical disruption
is dependent on an intercellular calcium wave propagated from
the site of disruption to adjacent cells [31–33], and STC1 was orig-
inally described as an endocrine regulator of calcium and phos-
phate homeostasis in ﬁsh [5]. Pretreatment of the A549
monolayer with rhSTC1 dramatically enhances extracellular ATP-
induced calcium wave propagation following scratch wounding
[24]. Recently, STC1 overexpression was reported to promote
lamellipodia formation and cell migration in a human epidermal
keratinocyte cell line (HaCaT) [16]. As shown in Fig. 3A and B in
the present study, the effect of recombinant STC1 on wound clo-
sure was modest, but we speculate that many potential molecules,
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of wound closure in AECs. Our laboratory has previously demon-
strated the critical role of KGF and HGF in repair of the alveolar epi-
thelium [22,34]. Further studies are necessary to elucidate the
interaction of diverse growth factors, including STC1, in initiating
AEC wound healing responses.
STC1 has also been shown to suppress oxidative damage, cell
apoptosis and the proinﬂammatory pathway such as NFkB activa-
tion and induction of TNFa and CXCL2 [14,35,36] through induc-
tion of UCP2 [17,26]. Many lung diseases, including ARDS,
emphysema, and many forms of interstitial lung disease are
inﬂammatory diseases, involving apoptosis of the endothelium
and alveolar epithelium and oxidative damage [23,37]. Thus, we
wondered whether STC1 would protect LPS-stimulated rat AECs
from oxidative damage through UCP2. Consistent with previous
reports, we found that LPS induced oxidative damage (carbonyl
protein) [19,38] and led to down-regulation of UCP2 [17,19,25].However, we did not observe inhibition of oxidative damage or
up-regulation of UCP2 by rhSTC1 in our model. Interestingly, Tang
et al. recently demonstrated that STC1 ameliorates LPS-induced
pulmonary oxidative stress, inﬂammation and apoptosis in mice
[19]. However, they did not consider which type of lung cells are
targeted by STC1. In addition, although current evidence supports
the local action of STCs in Ca2+ and Pi transport [39], at present,
information about the sequence, expression and distribution of
the STC receptor(s) is lacking.
In summary, we have demonstrated that STC1 is regulated by
hypoxic conditions and HIF in AECs and enhances wound healing
moderately in rat AEC monolayers. However, STC1 did not inhibit
oxidative damage in rat AECs stimulated by LPS in vitro. Previous
reports and our results suggest that STC1 has a potential role in
the resolution of various lung diseases. However, further investiga-
tions are required to determine which types of cells are target of
STC1, and the identiﬁcation of STC1 receptors in lungs.
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